Cargando…
Highlights of Strategies Targeting Fibroblasts for Novel Therapies for Rheumatoid Arthritis
Synovial fibroblasts of rheumatoid arthritis (RA) play a critical role in perpetuation of chronic inflammation by interaction with immune and inflammatory cells and in cartilage and bone invasion, but current therapies for RA are not directly targeted fibroblasts. Selectively fibroblast targeted the...
Autor principal: | Chu, Cong-Qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891528/ https://www.ncbi.nlm.nih.gov/pubmed/35252279 http://dx.doi.org/10.3389/fmed.2022.846300 |
Ejemplares similares
-
The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis
por: Barker, Brianne E., et al.
Publicado: (2023) -
Sulfonylureas or biguanides is associated with a lower risk of rheumatoid arthritis in patients with diabetes: A nationwide cohort study
por: Su, Yu-Jih, et al.
Publicado: (2022) -
Editorial: Rheumatoid arthritis: Pathogenesis and target-treatments
por: Piantoni, Silvia, et al.
Publicado: (2023) -
Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy
por: Ouboussad, Lylia, et al.
Publicado: (2019) -
Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis
por: Sapart, Emillie, et al.
Publicado: (2022)